<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cure - Longevity and Healthspan</title>
    <link>https://wewillcure.com/insights/longevity-and-healthspan</link>
    <description>Latest content from Cure in Longevity and Healthspan</description>
    <language>en</language>
    <lastBuildDate>Tue, 16 Jun 2026 20:15:43 GMT</lastBuildDate>
    <atom:link href="https://wewillcure.com/insights/longevity-and-healthspan/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <guid>https://wewillcure.com/insights/investment/longevity-and-healthspan/vcs-funding-longevity-startups-in-2026</guid>
      <title><![CDATA[7 VCs Funding Longevity Startups in 2026]]></title>
      <link>https://wewillcure.com/insights/investment/longevity-and-healthspan/vcs-funding-longevity-startups-in-2026</link>
      <description><![CDATA[From early-stage senolytics to AI-driven drug discovery, these seven firms are actively writing checks in longevity biotech.]]></description>
      <pubDate>Fri, 29 May 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/48SZfAshath5aefJfUdR01/3bebc782436155e67f6196ac9bbeae29/vc_anti-aging_ver04.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/company-profiles/longevity-and-healthspan/anti-aging-and-longevity-startups-to-watch</guid>
      <title><![CDATA[9 Anti-Aging and Longevity Startups to Watch in 2026]]></title>
      <link>https://wewillcure.com/insights/company-profiles/longevity-and-healthspan/anti-aging-and-longevity-startups-to-watch</link>
      <description><![CDATA[A list of the most promising anti-aging and longevity startups to watch in 2026, featuring companies developing epigenetic reprogramming, senolytics, AI-driven drug discovery, and next-generation cell rejuvenation therapies.]]></description>
      <pubDate>Tue, 09 Dec 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/19p4m9LbDyqFmPfNt28bN4/bb1d01db3aada57a9597070f6b97b09e/Anti_Agent_copy.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/metabolic-diseases/longevity-and-healthspan/mvp-insights_article-cambrian-bios-drug-strategy-for-age-related-diseases</guid>
      <title><![CDATA[Cambrian Bio’s Drug Strategy for Age-Related Diseases]]></title>
      <link>https://wewillcure.com/insights/metabolic-diseases/longevity-and-healthspan/mvp-insights_article-cambrian-bios-drug-strategy-for-age-related-diseases</link>
      <description><![CDATA[Longevity drugs to head off diseases of aging and extend healthy lifespans are tantalizingly close, yet translating basic science discoveries to drugs still have hurdles to pass. James Peyer, PhD, CEO and Founder of Cambrian Bio talks about pursuing treatments that extend human healthspans.]]></description>
      <pubDate>Wed, 17 Jul 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5etw3M0sh6DnxjFKUGpakM/01369c47a9060b479e7fccb2a64d1e3b/thumbnail_cambrian_Bios_Drug_Strategy_age-related.jpg" medium="image" />
      <category>Article</category>
    </item>
  </channel>
</rss>